Icagen Announces Extension of Pfizer Collaboration
September 21, 2009 08:15 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 21, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced a one year extension to a prior worldwide collaboration and licensing agreement with Pfizer...
Icagen Reports Top Line Results of Phase IIa Study of Senicapoc in Allergic Asthma
September 01, 2009 08:00 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 1, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today top line results of a randomized, double-blind, placebo-controlled, proof-of-mechanism Phase...
Icagen to Present At Upcoming Healthcare Conferences
August 31, 2009 08:00 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 31, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in two upcoming healthcare conferences as follows:...
Icagen Reports Second Quarter 2009 Financial Results
August 04, 2009 08:00 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 4, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the second quarter ended June 30, 2009....
Icagen Announces Lifting of Partial Clinical Hold of ICA-105665
August 03, 2009 06:30 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 3, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today that the FDA has lifted the partial clinical hold related to the development of ICA-105665, the...
Icagen to Report Second Quarter 2009 Results On August 4, 2009
July 23, 2009 08:00 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., July 23, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced plans to release second quarter 2009 financial results on Tuesday, August 4, 2009 before the...
Icagen Completes Enrollment in Phase II Exercise Induced Asthma Trial
June 12, 2009 08:00 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., June 12, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported the completion of enrollment in the Company's Phase II proof-of-concept study of senicapoc in...
Icagen Provides Strategic Update
June 04, 2009 16:36 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., June 4, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that the Company has retained J.P. Morgan to provide advice and assistance on a range of...
Icagen Reports First Quarter 2009 Financial Results and Operational Highlights
May 05, 2009 08:00 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., May 5, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the first quarter ended March 31, 2009. For...
Icagen to Report First Quarter 2009 Results On May 5, 2009
April 24, 2009 08:00 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 24, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced plans to release first quarter 2009 financial results on Tuesday, May 5, 2009 before the...